Pnc Financial Services Group, Inc. Global Blood Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$32.4 - $68.18 $45,522 - $95,792	-1,405 Reduced 99.65%	5 $0
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $11,551 - $19,368	-518 Reduced 26.87%	1,410 $45,000
Q1 2022 May 12, 2022	SELL	$25.68 - $35.59 $50,974 - $70,646	-1,985 Reduced 50.73%	1,928 $66,000
Q4 2021 Feb 11, 2022	SELL	$24.9 - $40.26 $11,130 - $17,996	-447 Reduced 10.25%	3,913 $114,000
Q3 2021 Nov 05, 2021	BUY	$25.48 - $37.34 $16,256 - $23,822	638 Added 17.14%	4,360 $111,000
Q2 2021 Aug 06, 2021	SELL	$32.46 - $43.42 $14,736 - $19,712	-454 Reduced 10.87%	3,722 $130,000
Q1 2021 May 07, 2021	SELL	$38.94 - $50.85 $1,791 - $2,339	-46 Reduced 1.09%	4,176 $170,000
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $87,724 - $148,584	-2,330 Reduced 35.56%	4,222 $182,000
Q3 2020 Nov 06, 2020	SELL	$52.76 - $74.49 $1,213 - $1,713	-23 Reduced 0.35%	6,552 $361,000
Q2 2020 Aug 07, 2020	BUY	$48.73 - $81.82 $33,769 - $56,701	693 Added 11.78%	6,575 $415,000
Q1 2020 May 08, 2020	BUY	$41.72 - $87.2 $63,831 - $133,416	1,530 Added 35.16%	5,882 $300,000
Q4 2019 Feb 07, 2020	SELL	$45.7 - $81.86 $20,747 - $37,164	-454 Reduced 9.45%	4,352 $345,000
Q3 2019 Nov 08, 2019	BUY	$45.35 - $57.91 $20,588 - $26,291	454 Added 10.43%	4,806 $233,000
Q4 2018 Feb 08, 2019	SELL	$31.54 - $46.67 $31 - $46	-1 Reduced 0.02%	4,352 $178,000
Q3 2018 Nov 09, 2018	BUY	$38.0 - $51.1 $145,730 - $195,968	3,835 Added 740.35%	4,353 $0
Q2 2018 Aug 10, 2018	BUY	$38.7 - $50.15 $7,817 - $10,130	202 Added 63.92%	518 $0
Q1 2018 May 11, 2018	BUY	$39.6 - $65.9 $11,484 - $19,111	290 Added 1115.38%	316 $0
Q4 2017 Feb 09, 2018	BUY	$29.7 - $45.7 $772 - $1,188	26	26 $0

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account